FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099670 [Registered on: 22/12/2025] Trial Registered Prospectively
Last Modified On: 22/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani
Other (Specify) [Qurs]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study to Compare Banadiqul Bazoor with Nitrofurantoin for Treating Acute Cystitis (Warm-e-Masana Had) 
Scientific Title of Study   An Open-Labelled Randomised Controlled Clinical Trial to Evaluate the Safety & Efficacy of Banadiqul Bazoor in Cases of Warm-e-Masana (Had Acute Cystitis) with Nitrofurantoin 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Maankala Sreekanth 
Designation  PG Scholar 
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD Room No. 107, PG Department of Moalajat, General Medicine, Government Nizamia Tibbi College and General Hospital, Charminar

Hyderabad
TELANGANA
500002
India 
Phone  9347016271  
Fax    
Email  Srikanthmankala773@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  N Narasimha 
Designation  Professor 
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD Room No. 107, PG Department of Moalajat, General Medicine, Government Nizamia Tibbi College and General Hospital, Charminar

Hyderabad
TELANGANA
500002
India 
Phone  9866985269  
Fax    
Email  dr.n.narasimha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  N Narasimha 
Designation  Professor 
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD Room No. 107, PG Department of Moalajat, General Medicine, Government Nizamia Tibbi College and General Hospital, Charminar

Hyderabad
TELANGANA
500002
India 
Phone  9866985269  
Fax    
Email  dr.n.narasimha@gmail.com  
 
Source of Monetary or Material Support  
Government Nizamia Tibbi College And General Hospital, Charminar, Hyderabad, Telangana-500002 
 
Primary Sponsor  
Name  Government Nizamia Tibbi College and General Hospital 
Address  Government Nizamia Tibbi College and General Hospital, Charminar, Hyderabad, Telangana, 500002 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Maankala Sreekanth  Govt. Nizamia Tibbi College and General Hospital  OPD Room No. 107, PG Department of Moalajat, General Medicine Govt. Nizamia Tibbi College and General Hospital, Charminar
Hyderabad
TELANGANA 
9347016271

Srikanthmankala773@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Government Nizamia Tibbi College, Hyderabad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N300||Acute cystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Banadiqul Bazoor  Therapy Duration: 30 days Sample Size: 25 participants Treatment Plan: Group A: Banadiqul Bazoor — 2 tablets BD (twice daily) after meals for 30 days, with follow-ups at 10-day intervals. 
Comparator Agent  Tablet Nitrofurantoin 100 mg  Therapy Duration: 30 days Sample Size: 25 participants Treatment Plan: Group B: Tablet Nitrofurantoin 100 mg — one tablet BD (twice daily) after meals for 10 days. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Age limit 18-60 years.
Sex-Both sexes.
Patients with burning micturition.
Patients with dysuria.
Patients with urgency of urine.
Patients with frequency of micturition. 
 
ExclusionCriteria 
Details  Patients with pregnancy and lactation.
Patients with renal calculi & vesicle calculi .
Patients with uncontrolled hypertensive .
Patients with uncontrolled diabetic .
Patients with systemic illness like cardiac failure, renal failure, hepatic failure etc. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the safety and efficacy of banadiqul bazoor in cases of warm e masana  Once in two weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the safety and efficacy of Nitrofurantoin in cases of warm e masana  Once in two weeks 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Cystitis Inflammation of the urinary bladder  associated with Dysuria increased frequency of urine and Suprapubic painUrinary tract infection more frequently in women than men it is estimated that more than 30percent of women will experience at least one episode of cystitis in their life timeMore than 7 million uncomplicated UTIs occur in US

According to Buqrat indisease was caused by alteration in kamiyat quantity aur kaifiyat quality of Akhlath that is alteration in mizaj temperament of akhlath of any organ This holds good to infections as well as metabolic diseases Warm e masana haad is caused by gair tabayyi safravi and damvi madda This abnormal madda leads to hiddath and hiddath leads to infection Warm e masana haad is caused by gair tabayyi safravi and damvi madda This abnormal madda leads to hiddath and hiddath leads to infection

 
Close